CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids
Yang, Mengbi3,4,5; Ma, Jiang3,4,5; Ruan, Jianqing3,4,5; Ye, Yang2,4,5; Fu, Peter Pi-Cheng1; Lin, Ge3,4,5
刊名ARCHIVES OF TOXICOLOGY
2019-08-01
卷号93期号:8页码:2197-2209
关键词Pyrrolizidine alkaloid N-oxides Pyrrolizidine alkaloids Pyrrolizidine alkaloid N-oxide toxicity Biotransformation of pyrrolizidine alkaloid N-oxides Microbiota biotransformation
ISSN号0340-5761
DOI10.1007/s00204-019-02499-2
通讯作者Lin, Ge(linge@cuhk.edu.hk)
英文摘要Pyrrolizidine alkaloids (PAs) are among the most significant groups of phytotoxins present in more than 6000 plants in the world. Hepatotoxic retronecine-type PAs and their corresponding N-oxides usually co-exist in plants. Although PA-induced hepatotoxicity is known for a long time and has been extensively studied, the toxicity of PA N-oxide is rarely investigated. Recently, we reported PA N-oxide-induced hepatotoxicity in humans and rodents and also suggested the association of such toxicity with metabolic conversion of PA N-oxides to the corresponding toxic PAs. However, the detailed biochemical mechanism of PA N-oxide-induced hepatotoxicity is largely unknown. The present study investigated biotransformation of four representative cyclic retronecine-type PA N-oxides to their corresponding PAs in both gastrointestinal tract and liver. The results demonstrated that biotransformation of PA N-oxides to PAs was mediated by both intestinal microbiota and hepatic cytochrome P450 monooxygenases (CYPs), in particular CYP1A2 and CYP2D6. Subsequently, the formed PAs were metabolically activated predominantly by hepatic CYPs to form reactive metabolites exerting hepatotoxicity. Our findings delineated, for the first time, that the metabolism-mediated mechanism of PA N-oxide intoxication involved metabolic reduction of PA N-oxides to their corresponding PAs in both intestine and liver followed by oxidative bioactivation of the resultant PAs in the liver to generate reactive metabolites which interact with cellular proteins leading to hepatotoxicity. In addition, our results raised a public concern and also encouraged further investigations on potentially remarkable variations in PA N-oxide-induced hepatotoxicity caused by significantly altered intestinal microbiota due to individual differences in diets, life styles, and medications.
资助项目Research Grant Council of Hong Kong[14110714] ; Research Grant Council of Hong Kong[14111816]
WOS关键词METABOLIC-ACTIVATION ; GASTROINTESTINAL-TRACT ; RAT-LIVER ; IN-VITRO ; HEPATOTOXICITY ; PLANTS ; TUMORIGENICITY ; RETRONECINE ; REDUCTION ; ZONATION
WOS研究方向Toxicology
语种英语
出版者SPRINGER HEIDELBERG
WOS记录号WOS:000483690200008
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/288715]  
专题中国科学院上海药物研究所
通讯作者Lin, Ge
作者单位1.US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
2.Chinese Acad Sci, Nat Prod Chem Dept, Shanghai Inst Mat Med, Shanghai, Peoples R China
3.Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China
4.Chinese Acad Sci, Joint Res Lab Promoting Globalizat Tradit Chinese, Shanghai, Peoples R China
5.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Yang, Mengbi,Ma, Jiang,Ruan, Jianqing,et al. Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids[J]. ARCHIVES OF TOXICOLOGY,2019,93(8):2197-2209.
APA Yang, Mengbi,Ma, Jiang,Ruan, Jianqing,Ye, Yang,Fu, Peter Pi-Cheng,&Lin, Ge.(2019).Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids.ARCHIVES OF TOXICOLOGY,93(8),2197-2209.
MLA Yang, Mengbi,et al."Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids".ARCHIVES OF TOXICOLOGY 93.8(2019):2197-2209.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace